-logo.jpg "ENDRA Life Sciences (Nasdaq: NDRA)"){kind=logo}
ENDRA Life Sciences (Nasdaq: NDRA)
Focused on early detection of liver disease
25 employees · est. 2009 · Ann Arbor, United States
Fibronostics
An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.
23 employees · est. 2015 · Orlando, United States
ENDRA Life Sciences (Nasdaq: NDRA) is the older company (2009 vs 2015).
Side-by-Side Comparison
| Metric | ENDRA Life Sciences (Nasdaq: NDRA) | Fibronostics |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2015 |
| Headquarters | ||
| Headquarters | Ann Arbor, United States | Orlando, United States |
| Employees | ||
| Employees | 25 | 23 |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Not tracked yet |
| Total Funding | ||
| Total Funding | $8.99M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Enhanced Ultrasound Technologies, TAEUS Platform, Liver Disease Detection, Non-Alcoholic Fatty Liver Disease (NAFLD), Medical Imaging Technology, Point-of-care Diagnostics, Liver Health Monitoring, Non-invasive Diagnostics, Healthcare Cost Reduction, Early Disease Detection, Medical Device Innovation, Liver Fat Quantification, Medical Technology Startups, Healthcare Accessibility | In Vitro Diagnostics, Metabolic Conditions, Artificial Intelligence, Diagnostic Testing, Liver Disease, NAFLD, NASH, Chronic Diseases, Coronary Heart Disease, Stroke, Diabetes, Obstructive Sleep Apnea, Non-invasive Diagnostics, Machine Learning |
| Website | ||
| Website | endrainc.com | fibronostics.com |
About ENDRA Life Sciences (Nasdaq: NDRA)
ENDRA Life Sciences Inc. (NDRA) is a biotechnology company headquartered in the United States and founded in 2007. The company's focus is on early detection of liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over 1 billion people globally and is estimated to cost...
About Fibronostics
Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibro...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at ENDRA Life Sciences (Nasdaq: NDRA) and Fibronostics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at ENDRA Life Sciences (N... and Fibronostics — by email.
Frequently Asked Questions
Compare ENDRA Life Sciences (Nasdaq: NDRA) with someone else
Start typing a company name or domain.